Skip to content

United Therapeutics UTHR Net Change in Cash

Net Change in Cash at other companies

Tenet Healthcare logo
Tenet HealthcareTHC
$84M+520%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.98B-86.2%
Merck & Co. logo
Merck & Co.MRK
-$9.29B-103%
Insmed logo
InsmedINSM
$71.74M+147%
Ethos Technologies, Inc.
 logo
Ethos Technologies, Inc. LIFE
-$1.17M+3.9%
LQD
Liquidia CorporationLQDA
$32.11M+578%

Other financials

Income statement

See full
Revenue$781.5M-1.6%
Gross profit$648.1M-7.7%
Operating income$325.8M-14.9%
Net income$274.9M-14.7%
EPS (diluted)$5.82-12.2%

Balance sheet

See full
Cash & equivalents$1.3B-32.6%
Total debt$12.2M
Total equity$5.9B-13.3%
Total assets$6.7B-13.3%

Cash flow

See full
Operating cash flow$463.3M+0.5%
CapEx$100.8M+34.6%
Free cash flow$362.5M-6.2%

Valuation

See full
Market cap$26.25B+90.4%
P/E20.4×+9.3×
P/S8.3×+3.8×

Profitability

See full
Gross margin86.6%-2.4pp
Operating margin45.3%-1.6pp
Net margin40.6%+0.2pp
FCF margin32.1%-5.6pp

Returns & leverage

See full
Return on equity20.3%+0.3pp
Debt / equity
Current ratio4.8×-0.7×

Where this comes from

Reported directly by United Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: United Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about United Therapeutics's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is United Therapeutics's net change in cash?
United Therapeutics (UTHR) reported net change in cash of -$277.4M in Q1 2026.
How has United Therapeutics's net change in cash changed year-over-year?
United Therapeutics's net change in cash decreased by 236.9% year-over-year, from $202.7M to -$277.4M.
What does net change in cash mean?
Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.